These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 33505430)

  • 1. Increased Expression of
    Xia S; Lin Y; Lin J; Li X; Tan X; Huang Z
    Front Genet; 2020; 11():605378. PubMed ID: 33505430
    [No Abstract]   [Full Text] [Related]  

  • 2. TICRR as a potential prognostic biomarker for lung adenocarcinoma: A comprehensive analysis using TCGA database.
    Zhang Z; Huang C; Wu J; Cheng Q; Wang S
    Medicine (Baltimore); 2024 Jul; 103(27):e38660. PubMed ID: 38968480
    [TBL] [Abstract][Full Text] [Related]  

  • 3.
    Zheng X; Han L; Guan J; Chen C; Zhang Y; Zhang J; Zhang Y; Liu S; Su J; Liu M; Huang H
    Front Oncol; 2023; 13():1274439. PubMed ID: 38152367
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comprehensive Analysis of TICRR in Hepatocellular Carcinoma Based on Bioinformatics Analysis.
    Chen JJ; Zhang LL; Liu Z; Men WQ; Chen F; Shen J
    Biochem Genet; 2024 Feb; 62(1):1-17. PubMed ID: 37266876
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High CENPA expression in papillary renal cell carcinoma tissues is associated with poor prognosis.
    Li J; Li Q; Yuan Y; Xie Y; Zhang Y; Zhang R
    BMC Urol; 2022 Sep; 22(1):157. PubMed ID: 36163007
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Three-gene risk model in papillary renal cell carcinoma: a robust likelihood-based survival analysis.
    Wang Y; Yan K; Lin J; Wang J; Zheng Z; Li X; Hua Z; Bu Y; Shi J; Sun S; Li X; Liu Y; Bi J
    Aging (Albany NY); 2020 Nov; 12(21):21854-21873. PubMed ID: 33154194
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genome-wide mutation profiling and related risk signature for prognosis of papillary renal cell carcinoma.
    Zhang C; Zheng Y; Li X; Hu X; Qi F; Luo J
    Ann Transl Med; 2019 Sep; 7(18):427. PubMed ID: 31700863
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bioinformatics profiling integrating a four immune-related long non-coding RNAs signature as a prognostic model for papillary renal cell carcinoma.
    Liu Y; Gou X; Wei Z; Yu H; Zhou X; Li X
    Aging (Albany NY); 2020 Jul; 12(15):15359-15373. PubMed ID: 32716909
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Cell Cycle-Related 13-mRNA Signature to Predict Prognosis in Hepatocellular Carcinoma.
    Zhou Y; Lei D; Hu G; Luo F
    Front Oncol; 2022; 12():760190. PubMed ID: 35419294
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Discovery and Validation of Survival-Specific Genes in Papillary Renal Cell Carcinoma Using a Customized Next-Generation Sequencing Gene Panel.
    Hwang J; Bang S; Choi MH; Hong SH; Kim SW; Lee HE; Yang JH; Park US; Choi YJ
    Cancers (Basel); 2024 May; 16(11):. PubMed ID: 38893126
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TICRR Overexpression Enhances Disease Aggressiveness and Immune Infiltration of Cutaneous Melanoma.
    Chen C; Zou Y; Zheng X; Hu T; Ni J; Kan D; Yin Z; Ye L; Liu B
    Pharmgenomics Pers Med; 2024; 17():423-435. PubMed ID: 39246575
    [TBL] [Abstract][Full Text] [Related]  

  • 12.
    Yu Q; Pu SY; Wu H; Chen XQ; Jiang JJ; Gu KS; He YH; Kong QP
    Front Oncol; 2019; 9():516. PubMed ID: 31275851
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identifying biomarkers of papillary renal cell carcinoma associated with pathological stage by weighted gene co-expression network analysis.
    He Z; Sun M; Ke Y; Lin R; Xiao Y; Zhou S; Zhao H; Wang Y; Zhou F; Zhou Y
    Oncotarget; 2017 Apr; 8(17):27904-27914. PubMed ID: 28427189
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Type II papillary histology predicts poor outcome in patients with renal cell carcinoma and vena cava thrombus.
    Kim KH; You D; Jeong IG; Kwon TW; Cho YM; Hong JH; Ahn H; Kim CS
    BJU Int; 2012 Dec; 110(11 Pt B):E673-8. PubMed ID: 22973869
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased expression of MMP17 predicts poor clinical outcomes in epithelial ovarian cancer patients.
    Xiao C; Wang Y; Cheng Q; Fan Y
    Medicine (Baltimore); 2022 Aug; 101(34):e30279. PubMed ID: 36042626
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Integrated Phenotypic/Genotypic Analysis of Papillary Renal Cell Carcinoma Subtypes: Identification of Prognostic Markers, Cancer-related Pathways, and Implications for Therapy.
    Saleeb RM; Plant P; Tawedrous E; Krizova A; Brimo F; Evans AJ; Wala SJ; Bartlett J; Ding Q; Boles D; Rotando F; Farag M; Yousef GM
    Eur Urol Focus; 2018 Sep; 4(5):740-748. PubMed ID: 28753789
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression Profiles and Clinical Significance of MicroRNAs in Papillary Renal Cell Carcinoma: A STROBE-Compliant Observational Study.
    Ge YZ; Xu LW; Xu Z; Wu R; Xin H; Zhu M; Lu TZ; Geng LG; Liu H; Zhou CC; Yu P; Zhao YC; Hu ZK; Zhao Y; Zhou LH; Wu JP; Li WC; Zhu JG; Jia RP
    Medicine (Baltimore); 2015 Apr; 94(16):e767. PubMed ID: 25906110
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ncRNAs-mediated high expression of TICRR promotes tumor cell proliferation and migration and is correlated with poor prognosis and tumor immune infiltration of hepatocellular carcinoma.
    He KJ; Zhang YF; Liang LY; Cheng XS; Gong G; Ouyang XM; Lin Y; Guleng B
    Mol Ther Nucleic Acids; 2022 Dec; 30():80-94. PubMed ID: 36213689
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In silico DNA methylation analysis identifies potential prognostic biomarkers in type 2 papillary renal cell carcinoma.
    Yang M; Hlady RA; Zhou D; Ho TH; Robertson KD
    Cancer Med; 2019 Sep; 8(12):5760-5768. PubMed ID: 31361072
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CDCA8 as an independent predictor for a poor prognosis in liver cancer.
    Shuai Y; Fan E; Zhong Q; Chen Q; Feng G; Gou X; Zhang G
    Cancer Cell Int; 2021 Mar; 21(1):159. PubMed ID: 33685433
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.